Bussini, L.; Bartoletti, M.; Bassetti, M.; Cortegiani, A.; De Pascale, G.; De Rosa, F. G.; Falcone, M.; Giannella, M.; Girardis, M.; Grossi, P.; Mikulska, M.; Navalesi, P.; Pea, F.; Sanguinetti, M.; Tascini, C.; Viaggi, B.; Viale, P., Role of liposomal amphotericin B in intensive care unit: an expert opinion paper, «JOURNAL OF ANESTHESIA, ANALGESIA AND CRITICAL CARE», 2025, 5, Article number: 23, pp. 1 - 17 [articolo]Open Access
Cojutti, Pier Giorgio; Pai, Manjunath P.; Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Targeting
Pseudomonas aeruginosa
resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, Early Access, Article number: e0104225, pp. 1 - 15 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; De Paola, Riccardo; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico, TDM-Based Approach for Properly Managing Intravenous Isavuconazole Treatment in a Complex Case Mix of Critically Ill Patients, «ANTIBIOTICS», 2025, 14, Article number: 777, pp. 1 - 12 [articolo]Open Access
Mulé, Giovanni; Coniglione, Giulia; Gatti, Milo; Cona, Andrea; Di Martino, Giuseppina; Ranucci, Giusy; De Ville De Goyet, Jean; Pea, Federico; Mularoni, Alessandra, TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipient, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 2550 - 2552 [articolo]Open Access
Cojutti, Pier Giorgio; Gatti, Milo; Tedeschi, Sara; Zamparini, Eleonora; Meschiari, Marianna; Danzi, Maria; Menegotto, Giacomo; Cotrufo, Marco; Soavi, Laura; Chiari, Erika; Ripa, Marco; Mazzitelli, Maria; Crapis, Massimo; Cattelan, Annamaria; Parruti, Giustino; Russo, Alessandro; Zammarchi, Lorenzo; Tascini, Carlo; Viale, Pierluigi; Pea, Federico, Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, Article number: e0183024, pp. 1 - 13 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Usefulness of a TDM-Guided Approach for Optimizing Teicoplanin Exposure in the Treatment of Secondary Bloodstream Infections Caused by Glycopeptide-Susceptible Enterococcus faecium, «MICROORGANISMS», 2025, 10.3390/microorganisms13010162, Article number: 162, pp. 1 - 12 [articolo]Open Access
Gatti, Milo; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim Analysis, «THERAPEUTIC DRUG MONITORING», 2025, 47, pp. 809 - 819 [articolo]Open Access
Gatti, Milo; Grimaldi, Pierantonio; Rinaldi, Matteo; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico, Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections, «JOURNAL OF ANESTHESIA, ANALGESIA AND CRITICAL CARE», 2025, 10.1186/s44158-025-00324-0, pp. 1 - 12 [articolo]
Conti, Matteo; Giorgi, Beatrice; Barone, Rossella; Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue, «PHARMACEUTICS», 2024, 10.3390/pharmaceutics16050681, Article number: 681, pp. 1 - 12 [articolo]Open Access
Cojutti, Pier Giorgio; Pai, Manjunath P; Gatti, Milo; Rinaldi, Matteo; Ambretti, Simone; Viale, Pierluigi; Pea, Federico, An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 10.1093/jac/dkae290, Article number: dkae290, pp. 1 - 12 [articolo]
Gatti, Milo; Pea, Federico, Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2024, 10.1128/aac.01453-24, pp. 1 - 3 [replica/breve intervento]
Cojutti, Pier Giorgio; Pai, Manjunath P.; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing
Enterobacterales, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2024, 68, Article number: e0140423, pp. 1 - 11 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 10.1093/jac/dkae261, pp. 1 - 4 [articolo]
Gatti, Milo; Cosentino, Federica; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Clinical efficacy of cefiderocol-based regimens in patients affected by carbapenem-resistant Acinetobacter baumannii infections: a systematic review with meta-analysis, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 63, Article number: 107047, pp. 1 - 5 [articolo]
Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP, «ANTIBIOTICS», 2024, 13, Article number: 296, pp. 1 - 16 [articolo]Open Access
